Proposed pharma marketing legislation

This is what kills me about my job—I was just laying out an article I wrote about state regulations related to pharma marketing for the July/August issue of Medical Meetings, and it was too long. Way too long. So I had to cut it in half. The good news, if you're interested in what's pending now, is that I put the extra half online here. I hope someone finds it and reads it—I'd hate to think all that work went for nothing! The rundown of what's already on the books in five states and Washington, D.C., will be out when July/August comes online (though if anyone's interested, I'd be glad to e-mail you a sneak peek).

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.